JP2010540618A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010540618A5 JP2010540618A5 JP2010527596A JP2010527596A JP2010540618A5 JP 2010540618 A5 JP2010540618 A5 JP 2010540618A5 JP 2010527596 A JP2010527596 A JP 2010527596A JP 2010527596 A JP2010527596 A JP 2010527596A JP 2010540618 A5 JP2010540618 A5 JP 2010540618A5
- Authority
- JP
- Japan
- Prior art keywords
- infant
- formulation
- growth
- promoting
- development
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims description 28
- 230000001737 promoting effect Effects 0.000 claims description 28
- 229930003827 cannabinoid Natural products 0.000 claims description 25
- 239000003557 cannabinoid Substances 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 23
- 238000009472 formulation Methods 0.000 claims description 22
- 239000008194 pharmaceutical composition Substances 0.000 claims description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- 235000013350 formula milk Nutrition 0.000 claims description 18
- 239000002621 endocannabinoid Substances 0.000 claims description 12
- 239000012669 liquid formulation Substances 0.000 claims description 8
- BBNYCLAREVXOSG-UHFFFAOYSA-N 2-palmitoylglycerol Chemical group CCCCCCCCCCCCCCCC(=O)OC(CO)CO BBNYCLAREVXOSG-UHFFFAOYSA-N 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 6
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims description 6
- 229930195729 fatty acid Natural products 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 6
- -1 fatty acid glycerol ester Chemical class 0.000 claims description 6
- 208000037824 growth disorder Diseases 0.000 claims description 6
- RCRCTBLIHCHWDZ-DOFZRALJSA-N 2-arachidonoylglycerol Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)OC(CO)CO RCRCTBLIHCHWDZ-DOFZRALJSA-N 0.000 claims description 3
- IEPGNWMPIFDNSD-HZJYTTRNSA-N 2-linoleoylglycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(CO)CO IEPGNWMPIFDNSD-HZJYTTRNSA-N 0.000 claims description 3
- LGEQQWMQCRIYKG-DOFZRALJSA-N anandamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCO LGEQQWMQCRIYKG-DOFZRALJSA-N 0.000 claims description 3
- LGEQQWMQCRIYKG-UHFFFAOYSA-N arachidonic acid ethanolamide Natural products CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCO LGEQQWMQCRIYKG-UHFFFAOYSA-N 0.000 claims description 3
- 230000015556 catabolic process Effects 0.000 claims description 3
- 238000006731 degradation reaction Methods 0.000 claims description 3
- 229960003638 dopamine Drugs 0.000 claims description 3
- 229940125532 enzyme inhibitor Drugs 0.000 claims description 3
- 239000002532 enzyme inhibitor Substances 0.000 claims description 3
- 239000003112 inhibitor Substances 0.000 claims description 3
- IEPGNWMPIFDNSD-UHFFFAOYSA-N linoleic acid monoacylglycerol Natural products CCCCCC=CCC=CCCCCCCCC(=O)OC(CO)CO IEPGNWMPIFDNSD-UHFFFAOYSA-N 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 150000001200 N-acyl ethanolamides Chemical class 0.000 claims 7
- 238000000034 method Methods 0.000 description 11
- 235000013305 food Nutrition 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96051207P | 2007-10-02 | 2007-10-02 | |
| PCT/IL2008/001314 WO2009044402A1 (en) | 2007-10-02 | 2008-10-02 | Endocannabinoids for enhancing growth and development in infants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010540618A JP2010540618A (ja) | 2010-12-24 |
| JP2010540618A5 true JP2010540618A5 (https=) | 2011-11-24 |
Family
ID=40239593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010527596A Pending JP2010540618A (ja) | 2007-10-02 | 2008-10-02 | 幼児の成長および発達を増大するための内在性カンナビノイド |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20110172305A1 (https=) |
| EP (1) | EP2205240A1 (https=) |
| JP (1) | JP2010540618A (https=) |
| CN (1) | CN101998855A (https=) |
| WO (1) | WO2009044402A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220071922A1 (en) * | 2018-12-26 | 2022-03-10 | Clear Lake Research, Llc | Delivery of health benefits through component formulation |
| CN111202767A (zh) * | 2019-09-04 | 2020-05-29 | 汉义生物科技（北京）有限公司 | 大麻全草提取物在改善tau蛋白和β-淀粉样蛋白病理损伤中应用 |
| US11206843B1 (en) * | 2020-05-26 | 2021-12-28 | BIOMILQ, Inc. | Milk product compositions |
| CN114748429A (zh) | 2020-12-29 | 2022-07-15 | 汉义生物科技（北京）有限公司 | 一种水溶性大麻素制剂及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE52535B1 (en) * | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| EP0545913B1 (en) * | 1986-08-18 | 1999-02-24 | Emisphere Technologies, Inc. | Delivery systems for pharmacological agents |
| US4897268A (en) * | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
| IL132661A (en) | 1999-10-31 | 2008-11-26 | Raphael Mechoulam | Agonists specific for peripheral cannabinoid receptors |
| ATE277608T1 (de) * | 2000-06-23 | 2004-10-15 | Yissum Res Dev Co | 2-arachidonylglycerol, ein hemmer des tumor nekrose faktors -alfa und neuroprotektor des gehirns bei geschlossenen kopfverletzungen |
| GB0104268D0 (en) * | 2001-02-21 | 2001-04-11 | Unilever Plc | Antiperspirant or deodorant compositions |
| TW200407110A (en) | 2001-11-23 | 2004-05-16 | Astrazeneca Ab | New use for the treatment of gastroesophageal reflux disease |
| US6913778B2 (en) * | 2001-12-21 | 2005-07-05 | Wyeth | Infant formula compositions comprising increased amounts of alpha-lactalbumin |
-
2008
- 2008-10-02 EP EP08836529A patent/EP2205240A1/en not_active Withdrawn
- 2008-10-02 US US12/681,273 patent/US20110172305A1/en not_active Abandoned
- 2008-10-02 CN CN2008801188665A patent/CN101998855A/zh active Pending
- 2008-10-02 JP JP2010527596A patent/JP2010540618A/ja active Pending
- 2008-10-02 WO PCT/IL2008/001314 patent/WO2009044402A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2276356B1 (en) | Warming sensate composition | |
| MX338685B (es) | Formulaciones de solucion intravenosa de posaconacol estabilizadas mediante beta-ciclodextrina sustituida. | |
| JP2011516092A5 (https=) | ||
| WO2006113631A3 (en) | Bioenhanced compositions | |
| TNSN08505A1 (fr) | Compositions pharmaceutiques stabilisees comprenant de la fesoterodine | |
| NZ588583A (en) | Novel lipid formulations for nucleic acid delivery | |
| BRPI0517663A (pt) | composição farmacêutica, método para preparar a mesma, produto, e, método para tratar distúrbios cardiovasculares | |
| WO2008065097A3 (en) | Stabilized solid pharmaceutical composition of candesartan cilexetil | |
| RU2008143600A (ru) | Композиции и способы улучшения антиоксидантного статуса животных | |
| JP6038132B2 (ja) | ニチシノンを含む液体薬学的組成物 | |
| PL1750862T3 (pl) | Kompozycja farmaceutyczna zawierająca irbesartan | |
| JP2010540618A5 (https=) | ||
| WO2004069203A3 (en) | Oral compositions of fenretinide having increased bioavailability and methods of using the same | |
| JP2007537258A5 (https=) | ||
| MX2010004556A (es) | Formulacion farmaceutica de acido clavulanico. | |
| WO2009120885A3 (en) | Stabilizing lipid compositions for oral pharmaceutical agents | |
| JP2011525901A (ja) | ロスバスタチンカルシウム含有医薬組成物 | |
| JP2012144532A5 (https=) | ||
| WO2007107835A3 (en) | Stable liquid formulations of antiepileptic agents | |
| WO2006053089A3 (en) | Methods and formulations for making pharmaceutical compositions containing bupropion | |
| WO2010003465A3 (en) | A drug powder for inhalation administration and a process thereof | |
| WO2008144355A3 (en) | Stable, self-microemulsifying fenofibrate compositions | |
| JP5709499B2 (ja) | リボフラビン又はその誘導体の安定化 | |
| WO2007022105A3 (en) | Stable pharmaceutical compositions, processes for making the same, and methods of their use | |
| JP2010222275A (ja) | 糖尿病者用ドリンク剤 |